Small Molecule CDMO – End-to-End, Regulatory-Compliant, and Scalable API Manufacturing

As a Manufacturer & Solution Provider, Lianhe Aigen delivers integrated Small Molecule CDMO services, supporting global pharmaceutical companies from preclinical development to commercial API production.

Why Small Molecule CDMO Matters

Small molecules remain a cornerstone of pharmaceutical innovation. Partnering with a reliable Small Molecule CDMO ensures consistent quality, regulatory compliance, and scalable manufacturing throughout the drug development lifecycle.

Lianhe Aigen provides comprehensive Small Molecule CDMO services, including:

Preclinical API supply for early-stage research
Clinical-stage API manufacturing for IND-enabling studies
Commercial-scale API production for global markets

As a trusted Manufacturer & Solution Provider, we enable seamless integration from RSM to Drug Substance and commercial API supply, delivering regulatory-ready, risk-controlled, and scalable solutions.

Our Small Molecule CDMO Capabilities

Lianhe Aigen’s Small Molecule CDMO services include:

Preclinical API supply: supporting early-stage drug discovery with reproducible quality
Clinical-stage API manufacturing: scalable, controlled processes for clinical trials
Commercial-scale API production: reliable supply for regulatory-approved APIs
Process development & optimization: reproducible, risk-controlled manufacturing for complex molecules
Integrated CRDMO platform: seamless handover from RSM to Drug Substance to commercial APIs

Quality & Regulatory Compliance

Quality and compliance are central to our Small Molecule CDMO services:

Fully compliant with GxP regulations and ICH Q7 guidelines
Facilities successfully inspected by FDA, EMA, PMDA, TGA, KFDA, NMPA
Complete traceability of raw materials and intermediates
Robust change control and deviation management systems
Support for customer audits and regulatory filings

Our quality system ensures every batch is risk-controlled, consistent, and ready for regulatory submission.

Typical Project Scenarios

We deliver high-quality small molecule API manufacturing across project needs:

Preclinical-stage API supply for early drug candidates
Clinical-stage small molecule manufacturing for IND-enabling studies
Commercial-scale API production for regulatory-approved APIs
Technology transfer and process scale-up for reproducible commercial manufacturing

Why Partner with Lianhe Aigen

As a Manufacturer & Solution Provider, Lianhe Aigen combines:

End-to-end CRDMO capabilities covering RSM, Drug Substance, and commercial API stages
Proven record with FDA, EMA, PMDA, TGA, KFDA, NMPA inspections
Long-term, risk-controlled API supply for global pharmaceutical clients
Experienced team in process development, quality assurance, and regulatory compliance

Partnering with Lianhe Aigen ensures your Small Molecule CDMO supply chain is robust, compliant, and capable of supporting critical projects from preclinical to commercial stages.